Cougar Biotechnology, Inc. (CGRB) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 30 transactions totaling $2.2M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Jul 3, 2009 involved a transaction of 288,083 shares valued at $12.4M.
No significant insider buying has been recorded for CGRB in the recent period.
No significant insider selling has been recorded for CGRB in the recent period.
Based on recent SEC filings, insider sentiment for CGRB is bullish with an Insider Alignment Score of 80/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Cougar Biotechnology, Inc. (CGRB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CGRB stock, having executed 30 transactions in the past 90 days. The most active insider is Arie Belldegrun (Executive), who has made 23 transactions totaling $16.7M.
Get notified when executives and directors at CGRB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 3, 2009 | H. Auerbach Alan | Executive | Tender | 288,083 | $43.00 | $12.4M | Large |
| Jul 3, 2009 | Belldegrun Arie | Executive | Tender | 176,014 | $43.00 | $7.6M | Large |
| Jul 3, 2009 | Belldegrun Arie | Executive | Tender | 116,654 | $43.00 | $5.0M | Large |
| Jul 3, 2009 | Belldegrun Arie | Executive | Tender | 15,000 | $43.00 | $645.0K | Large |
| Jul 3, 2009 | Belldegrun Arie | Executive | Tender | 49,664 | $43.00 | $2.1M | Large |
| Jul 3, 2009 | Malley Thomas | Executive | Tender | 19,918 | $43.00 | $856.5K | Large |
| Jun 9, 2009 | A. Rosenwald Lindsay Md | Executive | Sale | 10,000 | $42.90 | $429.0K | |
| Feb 21, 2008 | Belldegrun Arie | Executive | Purchase | 4,700 | $27.00 | $126.9K | |
| Feb 21, 2008 | Belldegrun Arie | Executive | Purchase | 300 | $26.99 | $8.1K | |
| Feb 21, 2008 | Belldegrun Arie | Executive | Purchase | 300 | $26.99 | $8.1K | |
| Feb 21, 2008 | Belldegrun Arie | Executive | Purchase | 4,700 | $27.00 | $126.9K | |
| Dec 18, 2007 | Belldegrun Arie | Executive | Purchase | 15,000 | $30.50 | $457.5K | |
| Jul 31, 2007 | A. Rosenwald Lindsay Md | Executive | Exercise | 10,000 | $4.50 | $45.0K | |
| Jul 19, 2007 | Malley Thomas | Executive | Purchase | 8,068 | $21.75 | $175.5K | |
| Jul 18, 2007 | Malley Thomas | Executive | Purchase | 8,500 | $21.75 | $184.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 6 | $28.6M | 92.7% |
Purchase(P) | 16 | $1.8M | 5.7% |
Sale(S) | 1 | $429.0K | 1.4% |
Exercise (Options)(X) | 1 | $45.0K | 0.1% |
Conversion(C) | 2 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insiders at Cougar Biotechnology, Inc. are accumulating shares at an accelerated pace. With 4 insiders making 30 transactions totaling $1.8M in purchases versus $429.0K in sales, the net buying activity of $1.3M signals strong executive confidence. Arie Belldegrun (Executive) leads the buying activity with $16.7M in transactions across all time.